Keyword Connections

chmp

Journals

1

1 the oncologist

Research Groups

0

No Research Group Connected

Bibliographies

1

1 Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.